Weight Gain
Data on weight gain discussed by researchers at University of North Dakota
Published in Obesity and Diabetes Week, May 18th, 2009
"Modafinil possesses pharmacologic effects that could influence the weight gain associated with SGAs. The objective of this trial was to determine the effect of modafinil on olanzapine-associated weight gain. This study was a 3-week, randomized, double-blind, placebo-controlled trial. All subjects received olanzapine titrated to 10 mg/day. Concurrently, subjects were randomized to receive modafinil titrated to 200 mg/day or placebo. Weight and feeding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- American Gastroenterological Association
Calorie restriction causes temporal changes in liver metabolism - Elsevier Health Sciences
People of higher socioeconomic status choose better diets -- but pay more per calorie - NIH/National Institute of Environmental Health Sciences
New data analysis shows possible link between childhood obesity and allergies - Adipose Tissue
New adipose tissue study findings recently were published by researchers at Kagawa University, Medical Department - Aging
New research on aging from Washington University summarized - Alzheimer Disease
Latinos in Chicago and Suburbs Face Alarming Numbers of Cases of Alzheimer's Disease While Thousands More are at Risk of Being Diagnosed - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
